Eiichi Sasaki, Katsuhiro Masago, Yoshihito Kogure, Shiro Fujita, Akari Iwakoshi, Hiroaki Kuroda, Toyonori Tsuzuki, Koji Tsuta, Hirokazu Matsushita, Masahide Oki. Mucous Gland Adenoma of the Lung: A Neoplastic Counterpart of Mucinous Bronchial Glands. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2023. 36. 6. 100182-100182
Katsuhiro Masago, Hiroaki Kuroda, Eiichi Sasaki, Shiro Fujita, Shuichi Shinohara, Yusuke Sugita, Yusuke Takahashi, Hirokazu Matsushita. Association of the KRAS genotype and clinicopathologic findings of resected non-small-cell lung cancer: A pooled analysis of 179 patients. Cancer genetics. 2022. 268-269. 64-74
Katsuhiro Masago, Hiroaki Kuroda, Shiro Fujita, Eiichi Sasaki, Yusuke Takahashi, Shuichi Shinohara, Hirokazu Matsushita. Biological difference between L858R and exon 19 deletion contributes to recurrence-free survival of resected non-small cell lung cancer. Oncology. 2022. 101. 2. 117-125
Katsutoshi Seto, Junichi Shimizu, Katsuhiro Masago, Mitsugu Araki, Ryohei Katayama, Yukari Sagae, Shiro Fujita, Yoshitsugu Horio, Eiichi Sasaki, Hiroaki Kuroda, et al. Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancer. Cancer genetics. 2022. 266-267. 1-6